CEO Jacob Thaysen and CFO Ankur Dhingra will host a conference call at 1:30 pm Pacific Time (4:30 pm Eastern Time) the same day to unpack the results. The company invites analysts and shareholders to participate via a live webcast available through the investor relations portal on its website. Participants are encouraged to log in at least ten minutes early to avoid potential connection delays.

A recording of the discussion will remain accessible on the company’s site for 30 days following the event. Illumina maintains a dominant position in the clinical and research markets, providing tools that facilitate breakthroughs in oncology, reproductive health, and agricultural science.